JP2009509979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009509979A5 JP2009509979A5 JP2008532546A JP2008532546A JP2009509979A5 JP 2009509979 A5 JP2009509979 A5 JP 2009509979A5 JP 2008532546 A JP2008532546 A JP 2008532546A JP 2008532546 A JP2008532546 A JP 2008532546A JP 2009509979 A5 JP2009509979 A5 JP 2009509979A5
- Authority
- JP
- Japan
- Prior art keywords
- serpin
- granzyme
- cell
- composition
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108050000761 Serpin Proteins 0.000 claims 12
- 102000008847 Serpin Human genes 0.000 claims 12
- 239000003001 serine protease inhibitor Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 11
- 102000001398 Granzyme Human genes 0.000 claims 10
- 108060005986 Granzyme Proteins 0.000 claims 10
- 230000002401 inhibitory effect Effects 0.000 claims 10
- 241001465754 Metazoa Species 0.000 claims 9
- 230000009261 transgenic effect Effects 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 8
- 102000040430 polynucleotide Human genes 0.000 claims 8
- 108091033319 polynucleotide Proteins 0.000 claims 8
- 239000002157 polynucleotide Substances 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 6
- 210000001519 tissue Anatomy 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 claims 3
- 210000004153 islets of langerhan Anatomy 0.000 claims 3
- 241000251468 Actinopterygii Species 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 210000002216 heart Anatomy 0.000 claims 1
- 210000005003 heart tissue Anatomy 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 210000004923 pancreatic tissue Anatomy 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72179905P | 2005-09-29 | 2005-09-29 | |
| PCT/CA2006/001582 WO2007036028A1 (en) | 2005-09-29 | 2006-09-26 | Compositions for and methods of granzyme b inhibition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009509979A JP2009509979A (ja) | 2009-03-12 |
| JP2009509979A5 true JP2009509979A5 (enExample) | 2010-11-18 |
Family
ID=37899312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008532546A Pending JP2009509979A (ja) | 2005-09-29 | 2006-09-26 | グランザイムb阻害のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20070104699A1 (enExample) |
| EP (1) | EP1940458A4 (enExample) |
| JP (1) | JP2009509979A (enExample) |
| AU (1) | AU2006297036A1 (enExample) |
| CA (1) | CA2623957A1 (enExample) |
| WO (1) | WO2007036028A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7951776B2 (en) * | 2006-09-01 | 2011-05-31 | American Type Culture Collection | Methods for treatment of type 1 diabetes |
| CA2739512A1 (en) | 2007-10-01 | 2009-04-09 | The University Of British Columbia | Granzyme a and granzyme b diagnostics |
| JP5959800B2 (ja) * | 2007-10-01 | 2016-08-02 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | グランザイムbインヒビターを用いる解離,動脈瘤,およびアテローム性動脈硬化症の治療 |
| CA2819810A1 (en) * | 2010-12-06 | 2012-06-14 | The University Of British Columbia | Granzyme b inhibitor compositions, methods and uses for promoting wound healing |
| US11559590B2 (en) | 2016-07-01 | 2023-01-24 | The General Hospital Corporation | Granzyme B directed imaging and therapy |
| CN119345374A (zh) * | 2024-10-31 | 2025-01-24 | 南通大学 | 靶向颗粒酶b在帕金森病神经元退变免疫治疗药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266465A (en) * | 1989-06-23 | 1993-11-30 | The Trustees Of The University Of Pennsylvania | α-1-antichymotrypsin, analogues and methods of production |
| US5612194A (en) * | 1989-06-23 | 1997-03-18 | Trustees Of The University Of Pennsylvania | Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| US5674708A (en) * | 1989-06-23 | 1997-10-07 | Trustees Of The University Of Pennsylvania | α-1-antichymotrypsin analogues having elastase inhibitory activity |
| DE10121255A1 (de) * | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen |
| EP1474093A4 (en) * | 2002-02-04 | 2005-02-16 | Merck & Co Inc | Granzyme B INHIBITORS |
| US7074911B2 (en) * | 2002-09-25 | 2006-07-11 | Board Of Regents, The University Of Texas System | Endogenous granzyme B in non-immune cells |
| JP2005120070A (ja) * | 2003-03-10 | 2005-05-12 | Taisho Pharmaceut Co Ltd | エラスターゼ遊離抑制剤及び脳梗塞治療薬 |
| WO2004113523A1 (ja) * | 2003-06-18 | 2004-12-29 | Celestar Lexico-Sciences, Inc. | Granzyme BとGolgin-160との相互作用阻害剤 |
| JP2005060379A (ja) * | 2003-07-31 | 2005-03-10 | Dainippon Pharmaceut Co Ltd | 複素環式化合物からなる医薬 |
| SE0302487D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| EP1879448A2 (en) * | 2005-02-25 | 2008-01-23 | University of Chicago | Compositions and methods related to serpin spi6 |
-
2006
- 2006-09-26 US US11/527,373 patent/US20070104699A1/en not_active Abandoned
- 2006-09-26 CA CA002623957A patent/CA2623957A1/en not_active Abandoned
- 2006-09-26 WO PCT/CA2006/001582 patent/WO2007036028A1/en not_active Ceased
- 2006-09-26 JP JP2008532546A patent/JP2009509979A/ja active Pending
- 2006-09-26 EP EP06790747A patent/EP1940458A4/en not_active Withdrawn
- 2006-09-26 AU AU2006297036A patent/AU2006297036A1/en not_active Abandoned
-
2010
- 2010-09-07 US US12/876,574 patent/US20110083201A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Resch et al. | Transplanting marginal organs in the era of modern machine perfusion and advanced organ monitoring | |
| Stockmann et al. | Extracorporeal perfusion for the treatment of acute liver failure | |
| Nagamoto et al. | Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure | |
| Kim et al. | Up to 9‐day survival and control of thrombocytopenia following alpha1, 3‐galactosyl transferase knockout swine liver xenotransplantation in baboons | |
| Starzl | History of liver and other splanchnic organ transplantation | |
| BRPI0519783A2 (pt) | composições imunogênicas de pvc2 e métodos de produzir tais composições | |
| WO2005121369A3 (en) | Rna-containing microvesicles and methods therefor | |
| Watanabe et al. | GalT‐KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD 47 on porcine blood vessels | |
| Zhang et al. | Artificial matrix helps neonatal cardiomyocytes restore injured myocardium in rats | |
| JP2005534430A5 (enExample) | ||
| JP2009509979A5 (enExample) | ||
| Tatsumi et al. | Therapeutic effects of hepatocyte transplantation on hemophilia B | |
| Wu et al. | Multiple gene modifications of pigs for overcoming obstacles of xenotransplantation | |
| JP2005528124A5 (enExample) | ||
| JP2008526318A5 (enExample) | ||
| Cypel et al. | Extracorporeal lung perfusion | |
| Rosenthal et al. | Techniques for intrasplenic hepatocyte transplantation in the large animal model | |
| Meyburg et al. | Liver cell transplantation in children | |
| EP1906729A4 (en) | Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use | |
| CN102985532B (zh) | 胰岛的分离方法及用于保护胰岛组织的保护液 | |
| Duncan | Mechanical support for cardiac and respiratory failure in pediatric patients | |
| Blankensteijn et al. | New aspects of heterotopic liver transplantation | |
| Suzuki et al. | Selective cell dissemination into the heart by retrograde intracoronary infusion in the rat1 | |
| CN116286992A (zh) | 一种基于kferq序列的药物控制系统及其构建方法和应用 | |
| Li et al. | Transplantation of neonatal cardiomyocytes plus fibrin sealant restores myocardial function in a rat model of myocardial infarction |